Form 4: Annexon Director Carson Executes Stock Transactions Under 10b5-1 Trading Plan

William H. Carson, a director at Annexon, Inc., engaged in stock transactions on July 1, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• On July 1, 2024, William H. Carson, a director of Annexon, Inc., executed transactions involving the company's common stock.
• These transactions were carried out under a Rule 10b5-1 trading plan adopted on January 4, 2024.
• Carson acquired 3,200 shares of common stock at a weighted average price of $5, with individual trades ranging from $4.83 to $5.145.
• He also disposed of 12,800 shares.
• Following these transactions, Carson still beneficially owns an unspecified amount of Annexon, Inc. common stock.

Sentiment

Score: 5

Explanation: Neutral sentiment as the transactions are part of a pre-planned trading strategy. The sale of shares could be seen as slightly negative, but the existence of the 10b5-1 plan mitigates this.

Positives

• The use of a 10b5-1 trading plan suggests that the transactions were pre-planned and not based on insider information at the time of the trade.

Negatives

• The disposal of 12,800 shares by a director could be perceived negatively by investors, although it's part of a pre-arranged plan.

Risks

• While the transactions are under a 10b5-1 plan, significant sales by insiders can sometimes create negative market sentiment.

Industry Context

Insider transactions are common, and the use of 10b5-1 plans is a standard practice to avoid accusations of trading on non-public information. Investors often monitor these filings for insights into management's perspective on the company's stock.

Comparison to Industry Standards

• Monitoring insider transactions is a standard practice in the financial industry.
• Companies like Pfizer, Moderna, and Biogen are also subject to similar scrutiny regarding insider trading activities.
• The use of 10b5-1 trading plans is a common method employed by executives in these companies to manage their stock holdings while adhering to regulatory requirements.

Stakeholder Impact

• The transactions could have a minor impact on shareholder sentiment, depending on how they interpret the director's stock activity.

Key Dates